Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CDTX
Stock Latest News
The Fly
Cidara Therapeutics reaches target enrollment of Phase 3 ANCHOR trial
10d ago
CDTX
Premium
The Fly
Merck price target raised to $105 from $98 at BofA
16d ago
MRK
CDTX
Premium
The Fly
Cidara Therapeutics downgraded to Neutral from Buy at Guggenheim
16d ago
CDTX
Premium
The Fly
Merck expects over $5B opportunity from Cidara’s flu drug, Reuters reports
16d ago
MRK
CDTX
Premium
The Fly
Cidara Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
17d ago
CDTX
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
18d ago
DIA
MRK
Premium
The Fly
Cidara Therapeutics downgraded to Neutral from Overweight at JPMorgan
19d ago
CDTX
Premium
The Fly
Cidara downgraded to Sector Perform from Outperform at RBC Capital
19d ago
CDTX
Premium
The Fly
Midday Fly By: Walmart names new CEO, Merck acquires Cidara
19d ago
HD
NU
Premium
The Fly
Cidara Therapeutics downgraded to Hold from Buy at Needham
19d ago
CDTX
Premium
The Fly
Cidara Therapeutics rises 105.6%
19d ago
CDTX
Premium
The Fly
Cidara Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
19d ago
CDTX
Premium
The Fly
Cidara Therapeutics rises 104.8%
19d ago
CDTX
Premium
The Fly
Morning Movers: Cidara skyrockets following Merck buyout offer
19d ago
SR
TE
Premium
Company Announcements
Cidara Therapeutics Enters Merger Agreement with Merck
19d ago
8K
CDTX
Premium
The Fly
Merck to acquire Cidara Therapeutics for $221.50 per share in cash, or $9.2B
20d ago
MRK
CDTX
Premium
The Fly
Merck to acquire Cidara Therapeutics for $221.50 per share in cash, or $9.2B
20d ago
MRK
CDTX
Premium
The Fly
Cidara Therapeutics jumps 104% to $216.26 after Merck buyout offer
20d ago
MRK
CDTX
Premium
The Fly
Merck close to deal to acquire Cidara Therapeutics, FT reports
20d ago
MRK
CDTX
Premium
Company Announcements
Cidara Therapeutics’ Earnings Call Highlights CD388 Progress
25d ago
CDTX
Premium
The Fly
Cidara Therapeutics price target raised to $145 from $137 at RBC Capital
26d ago
CDTX
Premium
Ratings
Positive Outlook on Cidara Therapeutics: Progress in CD388 Flu Program and Strategic Trial Advancements
27d ago
CDTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
